Compounds > imiquimod
Page last updated: 2024-08-24

imiquimod and drospirenone

imiquimod has been researched along with drospirenone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Emons, G; Faber, M; Günthert, AR; Hellriegel, S; Knappe, G1

Other Studies

2 other study(ies) available for imiquimod and drospirenone

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives.
    European journal of obstetrics, gynecology, and reproductive biology, 2008, Volume: 137, Issue:1

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Androgen Antagonists; Androstenes; Case-Control Studies; Chlormadinone Acetate; Clobetasol; Contraceptives, Oral; Cyproterone Acetate; Female; Glucocorticoids; Humans; Imiquimod; Incidence; Nandrolone; Premenopause; Progesterone; Retrospective Studies; Risk Factors; Treatment Outcome; Vulvar Lichen Sclerosus

2008